Home › Research › Topics › patterns
patterns
6 studies tagged patterns, dated 2011-02-02 to 2025-07-10. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer's disease 2025-07-10
- Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern 2019-07-07
- Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease 2019-05-24
Studies
6 studies carry this tag.
Date range
2011 to 2025
Top journals
- Frontiers in neuroscience 1
- JAMA neurology 1
- Journal of neurovirology 1
- Journal of the neurological sciences 1
- Nature communications 1
6 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Synaptic loss strongly correlates with cognitive impairment in Alzheimer's disease (AD), yet the mechanism linking its origin and pattern remain unclear.
-
This study aimed to compare serum amyloid processing biomarkers among HIV subtype B (n = 25), HIV subtype C (n = 26), healthy HIV-negative controls (n = 18), and patients with Alzheimer's disease (AD; n = 24).
-
48/100
The role of innate immunity in dementia with Lewy bodies (DLB) has been little studied.
-
The R47H coding variant of the triggering receptor expressed on myeloid cells-2 (TREM2) increases the risk of Alzheimer's disease (AD) similar to apolipoprotein E4.
-
64/100
Among the 128 study participants, the 104 patients with early PD had a different CSF pattern compared with the 13 patients with progressive supranuclear palsy (baseline area under the receiver operating characteristic curve, 0.87; P < .0001) and the 30 control participants (baseline area under the receiver operating characteristic curve, 0.69; P = .0021).
-
We measured the levels of some biological metals: copper (Cu), iron (Fe), magnesium (Mg), manganese (Mn), and zinc (Zn) in the cerebrospinal fluid (CSF) in patients with neurodegenerative diseases (52 patients with amyotrophic lateral sclerosis (ALS)), 21 patients with Alzheimer's disease (AD), and 20 patients with Parkinson's disease (PD) by inductively coupled plasma mass spectrometry (ICP-MS).